The overall objective of this research project is to optimize initial guideline-compliant diagnostics in AML diseases by developing a molecular genetic panel for simultaneous determination of disease-associated genetic aberrations.
The aim of this R&D project is to optimize diagnostics in personalized oncology by developing an efficient analytical system for the exploration, validation, and translation of new molecular biomarkers.
